Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP790044.RAtLWN7k2wv3R-_6bTzRXfm2kUzY58IaQMBBVzqccEL1U130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP790044.RAtLWN7k2wv3R-_6bTzRXfm2kUzY58IaQMBBVzqccEL1U130_assertion type Assertion NP790044.RAtLWN7k2wv3R-_6bTzRXfm2kUzY58IaQMBBVzqccEL1U130_head.
- NP790044.RAtLWN7k2wv3R-_6bTzRXfm2kUzY58IaQMBBVzqccEL1U130_assertion description "[We also used 5-aza-2'-deoxycytidine (5-aza-CdR) treatment and DNA bisulphite sequencing to study the promoter methylation for a specific region of CXCL12 in breast tumour cell lines.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP790044.RAtLWN7k2wv3R-_6bTzRXfm2kUzY58IaQMBBVzqccEL1U130_provenance.
- NP790044.RAtLWN7k2wv3R-_6bTzRXfm2kUzY58IaQMBBVzqccEL1U130_assertion evidence source_evidence_literature NP790044.RAtLWN7k2wv3R-_6bTzRXfm2kUzY58IaQMBBVzqccEL1U130_provenance.
- NP790044.RAtLWN7k2wv3R-_6bTzRXfm2kUzY58IaQMBBVzqccEL1U130_assertion SIO_000772 20109227 NP790044.RAtLWN7k2wv3R-_6bTzRXfm2kUzY58IaQMBBVzqccEL1U130_provenance.
- NP790044.RAtLWN7k2wv3R-_6bTzRXfm2kUzY58IaQMBBVzqccEL1U130_assertion wasDerivedFrom befree-2016 NP790044.RAtLWN7k2wv3R-_6bTzRXfm2kUzY58IaQMBBVzqccEL1U130_provenance.
- NP790044.RAtLWN7k2wv3R-_6bTzRXfm2kUzY58IaQMBBVzqccEL1U130_assertion wasGeneratedBy ECO_0000203 NP790044.RAtLWN7k2wv3R-_6bTzRXfm2kUzY58IaQMBBVzqccEL1U130_provenance.